116 related articles for article (PubMed ID: 12484540)
1. Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists.
Chilmonczyk Z; Krajewski KJ; Cybulski J
Farmaco; 2002 Nov; 57(11):917-23. PubMed ID: 12484540
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.
Bronowska A; Leś A; Chilmonczyk Z; Filipek S; Edvardsen O; Ostensen R; Sylte I
Bioorg Med Chem; 2001 Apr; 9(4):881-95. PubMed ID: 11354671
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
[TBL] [Abstract][Full Text] [Related]
4. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
[TBL] [Abstract][Full Text] [Related]
5. The ligand-binding site of buspirone analogues at the 5-HT1A receptor.
Sylte I; Chilmonczyk Z; Dahl SG; Cybulski J; Edvardsen O
J Pharm Pharmacol; 1997 Jul; 49(7):698-705. PubMed ID: 9255714
[TBL] [Abstract][Full Text] [Related]
6. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A agonists induce central cholinergic antinociception.
Galeotti N; Ghelardini C; Bartolini A
Pharmacol Biochem Behav; 1997 Aug; 57(4):835-41. PubMed ID: 9259013
[TBL] [Abstract][Full Text] [Related]
8. Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.
Chilmonczyk Z; Szelejewska-Wozniakowska A; Cybulski J; Cybulski M; Koziol AE; Gdaniec M
Arch Pharm (Weinheim); 1997 May; 330(5):146-60. PubMed ID: 9237427
[TBL] [Abstract][Full Text] [Related]
9. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.
Chilmonczyk Z; Cybulski M; Iskra-Jopa J; Chojnacka-Wójcik E; Tatarczyńska E; Kłodzińska A; Leś A; Bronowska A; Sylte I
Farmaco; 2002 Apr; 57(4):285-301. PubMed ID: 11989808
[TBL] [Abstract][Full Text] [Related]
10. N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.
Fujio M; Togo Y; Tomozane H; Kuroita T; Morio Y; Katayama J; Matsumoto Y
Bioorg Med Chem Lett; 2000 Mar; 10(5):509-12. PubMed ID: 10743959
[TBL] [Abstract][Full Text] [Related]
11. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
12. The effects of azapirones on serotonin1A neurons of the dorsal raphe.
Matheson GK; Pfeifer DM; Weiberg MB; Michel C
Gen Pharmacol; 1994 Jul; 25(4):675-83. PubMed ID: 7958728
[TBL] [Abstract][Full Text] [Related]
13. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring.
Kim JA; Gillespie RA; Druse MJ
Alcohol Clin Exp Res; 1997 Oct; 21(7):1169-78. PubMed ID: 9347075
[TBL] [Abstract][Full Text] [Related]
14. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
15. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
Yocca FD
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
[TBL] [Abstract][Full Text] [Related]
16. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
17. Chronobiotic effects of gepirone, a potential antidepressant with 5HT1A receptor partial agonist properties.
Van Reeth O; Olivares E; Zhang Y; Tripathi B; Turek FW
Behav Pharmacol; 1999 Mar; 10(2):119-30. PubMed ID: 10780825
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
19. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
20. Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex.
Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
Eur J Pharmacol; 1996 Jun; 305(1-3):73-8. PubMed ID: 8813534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
